Properties of the COPD assessment test in a cross-sectional European study

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 29-35

  Jones, P W ^a   Brusselle, G ^c   Dal Negro, R W ^d   Ferrer, M ^e   Kardos, P ^g   Levy, M L ^b   Perez, T ⁱ   Soler Cataluna J J ^f   Van Der Molen, T ^k   Adamek, L ^j   Banik, N ^h  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d Orlandi General Hospital   (Italy)

^e HOSPITAL DEL MAR   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^g Maingau Hospital   (Germany)

^h GLAXOSMITHKLINE   (Germany)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j GLAXOSMITHKLINE   (France)

^k UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

Chronic obstructive pulmonary disease; Copd assessment test; Health related quality of life; Primary care

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BELGIUM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE ASSESSMENT TEST; CLINICAL PRACTICE; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EUROPE; FEMALE; FRANCE; GERMANY; HEALTH STATUS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NETHERLANDS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SCORING SYSTEM; SPAIN; UNITED KINGDOM;

ADULT; CROSS-SECTIONAL STUDIES; EUROPE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 79960186020     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00177210     Document Type: Article

References (18)

1. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. (Pubitemid 38807371)
2. The Global Initiative for Chronic Obstructive Lung disease (GOLD). Executive Summary: Global Strategy for the Diagnosis, Management, and Prevention of COPD. Medical Communications Resources, 2008. Available from www.goldcopd.com
3. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease. Lancet 1997; 349: 1498-1504.
4. Viegi G, Pistelli F, Sherrill DL, et al. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30: 993-1013. (Pubitemid 351194805)
5. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes of COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-469.
6. Meguro M, Barley EA, Spencer S, et al. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 2007; 132: 456-463.
7. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404. (Pubitemid 34256951)
8. Wijkstra PJ, TenVergert EM, Van Altena R, et al. Reliability and validity of the chronic respiratory questionnaire (CRQ). Thorax 1994; 49: 465-467. (Pubitemid 24170398)
9. Jones P, Harding G, Wiklund I, et al. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009; 18: 208-215.
10. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
11. Jones PW, Brusselle G, Dal Negro RW, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011; 1: 57-66.
12. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233. (Pubitemid 126433231)
13. Webster K, Odom L, Peterman A, et al. The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: validation of version 4 of the core questionnaire. Qual Life Res 1999; 8: 604.
14. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586. (Pubitemid 29296676)
15. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969.
16. Wardlaw A, Silverman M, Siva R, et al. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005; 35: 1254-1262.
17. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-818.
18. Burgel P-R, Paillasseur J-L, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531-539.